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NEUROLOGICAL EVALUATION OF CHILDREN
AND ADOLESCENTS WITH BRAIN TUMOR,
BASED ON AMBULATORY-ORIENTED FOLLOW-UP
Alexandre Serafim¹, Luiz Celso Pereira Vilanova², Najla Saba Silva³
ABSTRACT - Taken as proved that brain tumors are the second most frequent childhood neoplasm - only
outnumbered by leukemias - we have undertaken a clinical perspective study with seventy brain tumor patients
ranging from one to fifteen years of age, throughout a four-year period (1993-1997), based on ambulatory-
oriented follow-up. Forty-one male and twenty-nine female patients were analyzed, in that a slightly higher
number of infratentorial tumors was observed (thirty-eight cases), compared to those supratentorially located
(thirty-two cases). The most repeatedly observed during the study was the medulloblastoma (twenty-one
patients), followed by the astrocytoma (fifteen patients) and the germinoma (eleven patients). It should be
pointed out that during the ambulatory follow-up 75,5% of patients developed neurological sequels. A tumor
recurrence was noticed in 34,3% of them, while 21,4% eventually died.
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Avaliação neurológica de crianças e adolescentes com tumor cerebral através de acompanhamento
ambulatorial
RESUMO - Considerando que os tumores cerebrais correspondem à segunda neoplasia mais freqüente na
infância, sendo apenas superados pelas leucemias, realizamos um estudo clínico prospectivo em setenta
pacientes com tumor cerebral, com idade variando de um a quinze anos, por um período de quatro anos
(1993-1997), através de acompanhamento ambulatorial. Avaliamos quarenta e um pacientes do sexo masculino
e vinte e nove do sexo feminino. Observamos uma freqüência discretamente maior de tumores infratentoriais
(38 casos) em relação aos de localização supratentorial (32 casos). O tumor mais freqüentimente observado
foi o meduloblastoma (21 casos), seguido pelo astrocitoma (15 casos) e pelo germinoma (11 casos). No
acompanhamento ambulatorial, observamos que 75,5% dos pacientes evoluíram com sequelas neurológicas.
Em 34,3% houve recidiva tumoral e 21,4% dos pacientes evoluíram para óbito.
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Brain tumors stand for the second most frequent
neoplasm in children and adolescents, only outnum-
bered by leukemias1-7. The morbidity and mortality
risks present in this pathology are distressful to family
members, and patients’ treatment-related tolerance
hardly proves satisfactory. The quality of life in sur-
viving patients is usually insufficient. The harmful
effects of this pathology on patients’ mental and phy-
sical health can be substantially reduced with early
diagnoses, fast therapy start-up and multi-profes-
sional ambulatory-based follow-up, thus enabling
greater support and comfort from family members.
The advances in neurological surgery techniques,
plus the association of chemical agents and new ra-
diotherapy techniques have been steadily enabling
higher rates related to patients’ survival and recov-
ery8. Hence, our attention should be focused on im-
proving these patients’ quality of life.
Consequently, our major goal was the study of
neurological clinical aspects related to children and
adolescents with brain tumor diagnosis, based on
perspective analyses and ambulatory-based follow-
up. The analyses of patients’ clinical evolution fo-
cused their neurological impairment, defining both
the presence and absence of sequels. The study also
comprised the correlation of these data with supra
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or infratentorial tumor location, just as aspects re-
garding their histology type, tumor recurrences and
deaths involved.
METHOD
The study was carried out at the Pediatric Oncology
Ambulatory of the São Paulo Federal University – São Paulo
Medical School (UNIFESP-EPM), from early March 1993
through March 1997. Seventy patients with brain tumor
diagnosis were examined, in that 41 were male and 29
female, ranging from 1 to 15 years of age.
The brain tumor location was determined by cranial
computed tomography and/or nuclear magnetic resonan-
ce, defining tumors located above the tentorium cerebeli
as supratentorial (32 tumors), and those below as infraten-
torial (38 tumors).
The tumor histology type was confirmed through ana-
tomic-pathological analyses, duly organized in accordance
with the brain tumor classification of the World Health Or-
ganization (WHO)9. Pursuant to the aforementioned classi-
fication, the following data were obtained: 29 patients
with embryonal tumors (21 cases of medulloblastoma and
8 cases of neuroectodermal primitive tumors), 25 patients
with neuroepithelial tumors (14 cases of astrocytoma, 3
cases of ependymomas, 3 cases of glioma, 2 cases of glio-
blastoma multiforme, 1 case of multiform ganglioma, 1
case of oligodendroglioma and 1 case of oligoastrocy-
toma), 11 patients with germinal cell tumors (all germino-
mas); 5 patients with less frequent tumors were grouped
in our analysis as other tumors (2 cases of neurofibroma,
1 case of craniopharyngioma, 1 case of esthesioneuro-
blastoma and 1 case of Ewin’s sarcoma metastasis).
All patients were submitted to the initial neurological
clinical evaluation; later on, their follow-up was conducted
on ambulatory-oriented basis, with reevaluations made
every 3 months. The minimum follow-up period comprised
twelve months, while the maximum involved forty-eight.
Therefore, the study relied on perspective analyses and
ambulatory-based follow-up, which defined patients’ clini-
cal evolution and neurological impairment, both focusing
the presence or absence of sequels.
The data obtained were compared with the supra or
infratentorial tumor location, their histology type, even-
tual tumor recurrences and deaths. All patients included
in the study did not present neurological disorders prior
to their current illness.
Statistical method
Nonparametric tests were used to analyze the results,
taking into consideration the nature of variables studied.
The following tests were applied: 1. Chi square test (for
contingency tables)10, in order to compare the supratento-
rial or infratentorial tumor location, as far as the clinical
evolution is concerned (types of disorders observed over
the last neurological examination), according to tumor his-
tology type and corresponding recurrence; 2. Fisher exact
test10, for the study of clinical evolution as regards the
occurrence of deaths, taking the Cochran restrictions into
consideration; 3. Mc Nemar test11, geared to individually
compare the presence or absence of neurological sequels,
which was observed both over the first and last neuro-
logical evaluations, respectively.
The null hypothesis rejection level was fixed in 0.05 or
5% for all tests, in that significant values were identified
with an asterisk.
RESULTS
The ambulatory follow-up enabled the identifi-
cation of 57 patients who eventually developed neu-
rological sequels, whereas 13 of them did not (Table
1). These data were then compared to the tumor
histology type (Table 2), its supra or infratentorial
location (Table 3), recurrence (Table 4) and deaths
(Table 5).
DISCUSSION
The highest survival rates in brain tumor patients
have been reported in literature4,12-15 as connected
to improvement of surgical techniques and specific
treatment-related guidelines according to tumor his-
tology type, as far as the use of different chemical
agents, dose variations and advances in the use of
radiotherapy are concerned. Consequently, a grow-
ing number of patients are achieving a longer life
span, which enables an improved analysis of neuro-
logical disorders as regards patients’ clinical evolu-
tion. Brain tumor cases observed in individuals un-
der fifteen years of age display a slight predominance
of tumor occurrence in male patients, when com-
pared to female patients2,16-22, just as the infratento-
rial location prevails over the supratentorial14,17,23-26.
Regarding the histology type, the medulloblastoma
and the astrocytoma have respectively been the most
frequently reported within this age bracket. Data
obtained in our series were in compliance with the
aforementioned literature.
The ambulatory-oriented follow-up enabled the
observation that clinical evolution involving neuro-
logical sequels prevailed over all histology types. This
predominance did not change as regards the suprat-
entorial and infratentorial location of tumors, nor
concerning tumor recurrence. The occurrence of neu-
rological sequels prevailed in patients who eventu-
ally died (15 cases); however, the statistical analysis
was not significant (Table 5).
References to neurological sequels during the fol-
low-up conducted for brain tumor diagnosed pa-
tients and regarding the supratentorial or infraten-
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Table 1. Clinical evolution of patients as far as the last neurologi-
cal evaluation is concerned.
Clinical evolution Nº
Normal 13
Ataxia + Dysmetria + Cranial Nerve (VII) 5
Hemiparesis 3
Epilepsy 3
Dual Hemiparesis + Cranial Nerve (IV) + Epilepsy 2
Visual Impairment + Cranial Nerve (III) 2
Hearing Impairment 2
Dysmetria 2
Visual Impairment + Precocious Puberty 2
Crural Diparesis 2
Hemiparesis + Epilepsy 2
Monoparesis + Hearing Impairment 1
Visual Impairment + Epilepsy 1
Dual Hemiparesis + Ataxia + Dysmetria
+ Hearing Impairment + Panhypopituitarism 1
Cranial Nerve (III) + Dysmetria 1
Precocious Puberty 1
Epilepsy + Diabetes Insipidus 1
Ataxia + Dysmetria + Epilepsy  1
Dysmetria + Ataxia + Dysarthria 1
Dual Hemiparesis + Cranial Nerve (VI,VII,IX,X) 1
Dual Hemiparesis + Dysmetria 1
Hemiparesis + Dysmetria 1
Crural Monoparesis + Dysmetria 1
Hearing Impairment + Cranial Nerve (IV) 1
Dual Hemiparesis + Ataxia + Dysmetria
+ Cranial Nerve (IX,X,XI) 1
Diabetes Insipidus 1
Hemiparesis + Epilepsy + Hearing Impairment 1
Diabetes Insipidus + Visual Impairment 1
Dysmetria + Epilepsy 1
Monoparesis + Epilepsy 1
Hemiparesis + Cranial Nerve (II,III,IV,VI) + Epilepsy 1
Cranial Nerve (IV) + Visual Impairment + Epilepsy 1
Cranial Nerve (III,IV,VI) 1
Hearing Impairment + Diabetes Insipidus 1
Dual Hemiparesis 1
Crural Diparesis + Dysmetria + Ataxia 1
Dysmetria + Hearing Impairment 1
Dual Hemiparesis + Epilepsy 1
Monoparesis + Hearing Impairment 1
Hemiparesis + Ataxia + Dysmetria 1
Hemiparesis + Cranial Nerve (III,IV) 1
Triparesis + Epilepsy 1
Dual Hemiparesis + Dystonia + Epilepsy 1
Tabela 2. Patients with brain tumor diagnosis; presence of se-
quels according to the clinical evolution and absence in accor-
dance with the last neurological clinical examination, as regards
the tumor histology type.
Tumors Clinical evolution Total
Presence Absence
of sequels of sequels
N % N % N %
Embryon. t. 20 68.9 9 31.1 29 100
Other neuroep. t. 23 92 2 8 25 100
Germ. cel. t. 10 90.9 1 9.1 11 100
Other tumors 4 80 1 20 5 100
Total 57 81.4 13 18.6 70 100
Embyon. t, Embryonal tumors; Other neuroep. t, Other neuroepithelial
tumors; Germ. cel. t, Germinal cell tumors; Chi square test: Calculated
Value = 5,487; Critical value = 7,81
Table 3. Patients with brain tumor diagnosis; presence of sequels
according to the clinical evolution and absence in accordance
with the last neurological clinical examination, as regards brain
tumor supratentorial or infratentorial location.
Location Clinical evolution Total Sequels
Presence Absence
of sequels of sequels
N % N % N % %
Supratentorial 27 47.4 5 38.5 32 45.7 84.4
Infratentorial 30 52.6 8 61.5 38 54.3 79.9
Total 57 100 13 100 70 100 81.4
Chi square test: Observed value = 0.18; Critical value = 3,84.
Table 4. Patients with brain tumor diagnosis; existence of se-
quels according to the clinical evolution and inexistence in accor-
dance with the last neurological examination, as regards pres-
ence and/or absence of tumor recurrence.
Recurrence Clinical evolution Total
Sequel Normal
N % N % N %
Present 24 88.9 3 11.1 27 100
Absent 33 76.7 10 23.3 43 100
Total 57 81.4 13 18.6 70 100
Chi square test: Observed value = 1,15; Critical value = 3,84.
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torial tumor location were not observed in litera-
ture.
Brain tumor histological characteristics, with re-
spect to their higher or lower level of malignancy, in
addition to analyses comprising their endothelial
proliferation capacity, necrosis, mitotic activity, nu-
clear atypia, brain tissue infiltration or compression
caused by mass effect in structures of the nervous
system are the major aspects that will eventually
determine a better or worse prognosis, as far as pa-
tients’ evolution is concerned, both in terms of survi-
val and quality of life4,15.
It should be mentioned that the brain tumor treat-
ment in itself (including surgeries, radiotherapy, che-
motherapy) is harmful to the brain tissue, thus in-
creasing the risk of sequels.
The neurological disorders in surviving patients
are related to the type of tumor and side effects on
impaired structures, therapeutic methods applied
and patients’ age13, 27- 32.
Radiotherapy can cause tardive effects on the
brain tissue14,27,31,32 and lead to alterations, namely,
leukoencephalopathies, formation of oncogenic ar-
eas, neuroendocrine disorders, and cognitive disor-
ders4,33-35. The neuroendocrine disorders are also
perceived in children submitted to radiotherapy, and
one of the major damages is the alteration of the
growth hormone secretion13. Less frequently ob-
served disorders are related to the secretion of go-
nadotrophins, panhypopituitarism and secondary
hypothyroidism36.
During the evaluation of practice-related abilities
in 342 adults who reported brain tumors under 20
years of age, Mostow et al.36 observed inability con-
nected to driving and conducting professional ac-
tivities when compared to a normal control group.
These results were mainly present in patients with
story of supratentorially located tumors and those
submitted to radiotherapy, which led us to conclude
that the standards related to quality of life in these
patients is low.
Within the prognosis of brain tumor-diagnosed
patients, the tumor recurrence and the involvement
of death is directly related to lower ages in tumor
occurrences, as well as to its histology type, malig-
nancy level, difficulties in tumor surgical resection
and the possibility of using proper radiotherapy
doses2,8,12,17.
Therefore, our study complies with the literature
analyzed, showing both the prompt and tardive
harmful effects related to the existence of a nervous
system tumor, impairing patients’ health and sur-
vival.
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